Most Popular Stories
- How do the 12 priciest drugs in the U.S. stack up?
- FDA approvals of 2011
- FDA rewards Roche with priority review for blockbuster cancer drug
- The 25 most influential people in biopharma today
- GSK will cut 3 R&D units, add 4 as DPU review triggers shakeup
- 13 Big Pharmas to collaborate on $785M fight against neglected diseases
Webinars
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
Featured Jobs
-
Manager Business Development
Clinical Resource Network - US West Coast -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US -
Assistant Director, Reimbursement Strategy and Trends
Xcenda - Charlotte, NC or remote -
Manager, Field Outsourcing
Xcenda - New Mexico, Kansas, Lubbock TX and Omaha
Events
- World Orphan Drug Congress USA 2012
10-13 April, 2012 — Gaylord National Resort and Convention Center, Washington, D.C. - DCAT Week 2012
Mar 12-15 — New York City - Pharmaceutical Strategic Outlook
April 11-13, 2012 - Just Released: New Trends in Preventive and Therapeutic Vaccine
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Can a R&D Tax Credit Expand Investment in Product Development for Global Health?
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
- Biologically Active Molecules: Chemical Research, Development and Scale-up
- Pharma 2.0: Heading Toward Social Media Marketing
- BRAND-NEW COMPOUNDS
- Niche Tourism Beginning and digital marketing : Beginning of the future?
Genzyme CEO Henri Termeer
